4//SEC Filing
Verwijs Marinus 4
Accession 0001415889-24-016994
CIK 0001798749other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:00 PM ET
Size
8.7 KB
Accession
0001415889-24-016994
Insider Transaction Report
Form 4
Verwijs Marinus
Senior Vice President, CMC
Transactions
- Exercise/Conversion
Common Stock
2024-06-14$14.59/sh+10,600$154,654→ 10,600 total - Sale
Common Stock
2024-06-14$25.00/sh−10,600$265,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-14−10,600→ 68,800 totalExercise: $14.59Exp: 2032-03-20→ Common Stock (10,600 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2023.
- [F2]25% of this option vested and became exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001916553
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:00 PM ET
- Size
- 8.7 KB